Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
January 2012
January 2012
NCT00988208Uploaded 03-11-2014
Available for Download
PDS UID: Prostat_Celgene_2009_90
A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone With or Without Lenalidomide in Subjects With Castrate-Resistant Prostate Cancer (CRPC)
PDS UID: Prostat_Multipl_2018_234Go to Study
Enhancing the Analytic Capacity of Prostate_Celgene_2009_90 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLCC-5013-PC-002 Final Protocol_Redacted.pdf
CRFblankCRF_RedactedMAINSAIL.pdf
DATA (COMPARATOR ARM)PC002_De-id_Database 2.zip